This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

Primarily due to recent advances of detection techniques, microchimerism (the proportion of
minor variant population is below 1%) has recently gained increasing attention in the field of …

We sought to evaluate the impact of cryopreservation of unrelated donor (URD) peripheral
blood stem cell (PBSC) grafts on engraftment, chimerism, and immune reconstitution in the …

Conventional analysis of host chimerism (HC) frequently fails to detect relapse before its
clinical manifestation in patients with hematological malignancies after allogeneic stem cell …

Chimerism refers to the relative proportion of donor and recipient DNA after hematopoietic
stem cell transplantation (HSCT) and its quantitative follow-up is of great clinical utility in this …

Recipient–donor chimerism is routinely analyzed after allogeneic hematopoietic stem cell
transplantation (HSCT) to monitor engraftment and graft rejection. For malignancies …

Although quantitative PCR (qPCR) has been explored for chimerism monitoring after
allogeneic stem cell transplantation (SCT), evidence regarding its clinical utility compared …

Chimerism testing is used to monitor engraftment and risk of relapse after allogeneic
hematopoietic stem cell transplantation for hematologic malignancies. Although short …

Blastocyst complementation (BC) systems have enabled in vivo generation of organs from
allogeneic pluripotent cells, compensating for an empty germ cell niche in gene knockout …

Chimerism monitoring after allogenic Hematopoietic Cell Transplantation (allo-HCT) is
critical to determine how well donor cells have engrafted and to detect relapse for early …